Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-24
1998-04-28
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546196, A61K 31445, C07D40504
Patent
active
057444838
ABSTRACT:
enantiomers and pharmaceutically acceptable salts are effective oral agents for treating diseases and conditions susceptible to treatment by NMDA blocking drugs.
REFERENCES:
patent: 3294804 (1966-12-01), Carobateas
patent: 3509164 (1970-04-01), Carron et al.
patent: 4016281 (1977-04-01), Jonas et al.
patent: 4048317 (1977-09-01), Watts
patent: 4082755 (1978-04-01), van Wijngaarden et al.
patent: 4304915 (1981-12-01), Berthold
patent: 4358456 (1982-11-01), Ward
patent: 4393069 (1983-07-01), Langbein et al.
patent: 4446113 (1984-05-01), Evans et al.
patent: 4610992 (1986-09-01), Evans et al.
patent: 4640928 (1987-02-01), Willcocks
patent: 4711899 (1987-12-01), Gaudilliere et al.
patent: 4902695 (1990-02-01), Ornstein
patent: 4957928 (1990-09-01), Froestl
patent: 4968678 (1990-11-01), Ornstein
patent: 4968878 (1990-11-01), Pong
patent: 5034401 (1991-07-01), Frost
patent: 5112855 (1992-05-01), Froestl
patent: 5192751 (1993-03-01), Thor
patent: 5356905 (1994-10-01), Butler
Chem. Abst., v. 89, p. 644, No. 43498y, 1978.
Chem. Abst., v. 89, p. 615, No. 146932q, 1978.
J. W. Olney, Annu. Rev. Pharmacol. Toxicol. 1990, 30:47-71.
J. P. Bonte et al., Eur. J. Med. Chem., 25, 1990, pp. 361-368.
C. Carron et al., Arzneim.-Forsch. (Drug Res.) 12, pp. 1992-1998, 1971.
K. A. Trujillo et al., Science, v. 251, pp. 85-87, 1991.
N. L. Harrison et al., J. Pharmac., 84, pp. 381-391, 1985.
D. E. Murphy et al., Br. J. Pharmacol., 95, pp. 932-938, 1988.
J. J. Hansen et al., Med. Res. Rev., 10(l), pp. 55-94, 1990.
H. Wachtel et al., TIPS, v. 11, pp. 219-220, 1990.
J. Kornhuber, TIPS, v. 11, p. 357, 1990.
J. Lehmann, Drugs of the Future, 14(11), pp. 1059-1071, 1989.
W. J. Schmidt et al., Pharmac. Biochem. & Behavior, v. 32, pp. 624-623, 1989.
I. A. Shalaby et al., J. Pharm. Exp. Therap., 260(2), pp. 925-931, 1992.
Chem. Abst. v. 89, p. 644, No. 43498y, 1978.
Chem. Abst. v. 89, p. 615, No. 146938w, 1978.
Butler Todd W.
Chenard Bertrand L.
Aulakh Charanjit S.
Ginsburg Paul H.
Ivy C. Warren
Pfizer Inc.
Richardson Peter C.
LandOfFree
Neuroprotective compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuroprotective compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuroprotective compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1532235